[go: up one dir, main page]

AU631407B2 - Magnesium folates, process for their preparation and pharmaceutical compositions - Google Patents

Magnesium folates, process for their preparation and pharmaceutical compositions

Info

Publication number
AU631407B2
AU631407B2 AU51941/90A AU5194190A AU631407B2 AU 631407 B2 AU631407 B2 AU 631407B2 AU 51941/90 A AU51941/90 A AU 51941/90A AU 5194190 A AU5194190 A AU 5194190A AU 631407 B2 AU631407 B2 AU 631407B2
Authority
AU
Australia
Prior art keywords
folates
magnesium
preparation
pharmaceutical compositions
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU51941/90A
Other versions
AU5194190A (en
Inventor
Jean-Bernard Le Polles
Dat Xuong Nguyen
Jean-Robert Rapin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panmedica SA
Original Assignee
Panmedica SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panmedica SA filed Critical Panmedica SA
Publication of AU5194190A publication Critical patent/AU5194190A/en
Application granted granted Critical
Publication of AU631407B2 publication Critical patent/AU631407B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU51941/90A 1989-02-14 1990-02-14 Magnesium folates, process for their preparation and pharmaceutical compositions Ceased AU631407B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8901899A FR2643081B1 (en) 1989-02-14 1989-02-14 MAGNESIUM FOLATES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS
FR8901899 1989-02-14

Publications (2)

Publication Number Publication Date
AU5194190A AU5194190A (en) 1990-09-05
AU631407B2 true AU631407B2 (en) 1992-11-26

Family

ID=9378770

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51941/90A Ceased AU631407B2 (en) 1989-02-14 1990-02-14 Magnesium folates, process for their preparation and pharmaceutical compositions

Country Status (6)

Country Link
EP (1) EP0461145A1 (en)
JP (1) JPH04505007A (en)
AU (1) AU631407B2 (en)
CA (1) CA2046341A1 (en)
FR (1) FR2643081B1 (en)
WO (1) WO1990009382A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU635831B2 (en) * 1990-04-12 1993-04-01 Sapec S.A. Fine Chemicals Ammonium salts of n5-methyl-5,6,7,8-tetrahydrofolic acid
AU654993B2 (en) * 1991-01-16 1994-12-01 Eprova Ag Process for the preparation of (6S)-and (6R)-tetrahydrofolates

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0432441B1 (en) * 1989-12-11 1996-06-26 American Cyanamid Company Process for the preparation of optically pure diastereoisomers of tetrahydrofolate compounds
CH684270A5 (en) * 1991-10-04 1994-08-15 Sapec Fine Chemicals A process for preparing alkaline earth metal salts of (6R) -N (10) formyl-5,6,7,8-tetrahydrofolic acid.
EP1121139A1 (en) * 1998-10-19 2001-08-08 MERCK PATENT GmbH Natural formulation for the treatment and prevention of depression, containing st john's wort and derivatives of dihydro- and tetrahydrofolic acid

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649550A5 (en) * 1984-02-09 1985-05-31 Eprova Ag Process for the preparation of alkaline earth metal salts of 5-methyltetrahydrofolic acid
AU3716189A (en) * 1988-06-29 1990-01-04 Eprova Ag Method for the preparation of tetrahydrofolates
AU4392489A (en) * 1988-11-11 1990-05-17 Eprova Ag Method for the separation of folinic acid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148999A (en) * 1977-08-22 1979-04-10 The Government Of The United States Of America Preparation and purification of citrovorum factor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649550A5 (en) * 1984-02-09 1985-05-31 Eprova Ag Process for the preparation of alkaline earth metal salts of 5-methyltetrahydrofolic acid
AU3716189A (en) * 1988-06-29 1990-01-04 Eprova Ag Method for the preparation of tetrahydrofolates
AU4392489A (en) * 1988-11-11 1990-05-17 Eprova Ag Method for the separation of folinic acid

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU635831B2 (en) * 1990-04-12 1993-04-01 Sapec S.A. Fine Chemicals Ammonium salts of n5-methyl-5,6,7,8-tetrahydrofolic acid
AU654993B2 (en) * 1991-01-16 1994-12-01 Eprova Ag Process for the preparation of (6S)-and (6R)-tetrahydrofolates

Also Published As

Publication number Publication date
AU5194190A (en) 1990-09-05
JPH04505007A (en) 1992-09-03
CA2046341A1 (en) 1990-08-15
FR2643081B1 (en) 1991-06-07
FR2643081A1 (en) 1990-08-17
EP0461145A1 (en) 1991-12-18
WO1990009382A1 (en) 1990-08-23

Similar Documents

Publication Publication Date Title
AU1252088A (en) Pharmaceutical composition, pharmaceutical granulate and process for their preparation
IL95045A0 (en) Thienodiazepine derivatives,their preparation and pharmaceutical compositions containing them
IL94082A0 (en) 3-n-substituted carbamoyl-indole derivatives,their preparation and pharmaceutical compositions containing them
IL92425A0 (en) Alpha-d-glucofuranose derivatives,pharmaceutical compositions containing the same and processes for the preparation thereof
AU6667290A (en) Pyridazine derivatives, process for their preparation and pharmaceutical compositions containing them
AU5212093A (en) Dihydro - and tetrahydro-isoquinolines, process for their preparation and pharmaceutical compositions containing same
IL93124A0 (en) Benzocycloalkenyldihydroxyalkanoic-acid derivatives,their preparation and pharmaceutical compositions
AU2366088A (en) 2,2-dimethylchromene derivatives, process for their preparation and pharmaceutical compositions in which they are present
IL98812A0 (en) Purine derivatives,process for their preparation and pharmaceutical compositions containing them
EP0285089A3 (en) 4-thioquinazoline derivatives, processes for their preparation and pharmaceutical compositions
IL97656A0 (en) Purine derivatives,process for their preparation and pharmaceutical compositions comprising them
IL94485A0 (en) Purine derivatives,process for their preparation and pharmaceutical compositions containing them
AU1563388A (en) New macrolide derivatives, process for the preparation thereof and pharmaceutical compositions containing them
AU8917891A (en) Poly-aminopyrrolecarboxamido derivatives, processes for their preparation and pharmaceutical compositions containing them
AU631407B2 (en) Magnesium folates, process for their preparation and pharmaceutical compositions
GB2235198B (en) Novel aminopropanol derivatives,process for their preparation and pharmaceutical compositions comprising the same
IL93477A0 (en) Steroid derivatives,pharmaceutical compositions containing them and process for their preparation
EP0418020A3 (en) Cephalosporinderivatives, process for their preparation and pharmaceutical compositions
IL86173A0 (en) Pyrrolidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
AU6488198A (en) Heteroarylpiperidines, process for their preparation and pharmaceutical compositions in which they are present
AU4756693A (en) 1-heteroarylazetidines and -pyrrolidines, process for their preparation and pharmaceutical compositions containing them
AU1833888A (en) 2,2-dimethylchroman-3-ol derivatives, process for their preparation and pharmaceutical compositions in which they are present
AU4373389A (en) New tylosin derivatives, process for the preparation thereof and pharmaceutical compositions containing them
AU5362890A (en) New macrolide derivatives, process for preparing them and pharmaceutical compositions containing them
AU621726B2 (en) New 5-acylbenzoxazolinone derivatives, processes for preparing them and pharmaceutical compositions containing them